These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 16312859

  • 1. Alpha interferon in the treatment of hairy cell leukemia.
    Tambone Reyes M, Gebbia V, Teresi M, Bonaccorso R, Colucci A, Quartararo L, Di Marco P, Citarrella P, Mansueto S.
    J Chemother; 1989 Jul; 1(4 Suppl):1264-5. PubMed ID: 16312859
    [No Abstract] [Full Text] [Related]

  • 2. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I, Zdziarska B, Krygier-Stojałowska A.
    Acta Haematol Pol; 1996 Jul; 27(1):49-55. PubMed ID: 8629443
    [Abstract] [Full Text] [Related]

  • 3. Alpha-interferon as induction and maintenance therapy in hairy-cell leukemia: a long-term follow-up analysis.
    Clavio M, Masoudi B, Spriano M, Casciaro S, Gobbi M, Damasio EE.
    Haematologica; 1999 May; 84(5):466-8. PubMed ID: 10329930
    [No Abstract] [Full Text] [Related]

  • 4. [Intermittent interferon alfa in the treatment of hairy cell leukemia].
    Gómez-Almaguer D, Jaime-Pérez JC, Herrera-Garza JL, González-Llano O.
    Rev Invest Clin; 1998 May; 50(4):331-4. PubMed ID: 9830322
    [Abstract] [Full Text] [Related]

  • 5. [50-year-old man with weight loss and splenomegaly].
    Austein T, Schmitt A.
    Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
    [No Abstract] [Full Text] [Related]

  • 6. Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia.
    Benz R, Stussi G, Fehr J.
    Br J Haematol; 2010 Feb; 148(4):664-5; author reply 665-6. PubMed ID: 19814738
    [No Abstract] [Full Text] [Related]

  • 7. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine.
    Zák P, Chrobák L, Podzimek K, Plísková L, Dedic K.
    Neoplasma; 1998 Feb; 45(4):261-5. PubMed ID: 9890671
    [Abstract] [Full Text] [Related]

  • 8. Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
    Juliusson G.
    Am J Hematol; 1996 Sep; 53(1):49. PubMed ID: 8813099
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K, Zák P.
    Neoplasma; 2004 Sep; 51(1):56-8. PubMed ID: 15004661
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia.
    Benz R, Siciliano RD, Stussi G, Fehr J.
    Eur J Haematol; 2009 Mar; 82(3):194-200. PubMed ID: 19077050
    [Abstract] [Full Text] [Related]

  • 16. Selective myeloid aplasia: a long-lasting presentation of an unusual hairy cell leukemia variant?
    Marinone GM, Roncoli B.
    Haematologica; 1993 Mar; 78(4):239-41. PubMed ID: 8294056
    [Abstract] [Full Text] [Related]

  • 17. Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation.
    Sgarabotto D, Zerbinati P, Vianello F, Valeri P, Girolami A, Dazzi F.
    Haematologica; 1992 Mar; 77(4):367-8. PubMed ID: 1427450
    [No Abstract] [Full Text] [Related]

  • 18. Hairy cell leukemia--results with alpha interferon therapy.
    Pai S, Shinde SC, Saikia TK, Gopal R, Nair CN, Advani SH.
    J Assoc Physicians India; 1999 Jun; 47(6):605-7. PubMed ID: 10999157
    [Abstract] [Full Text] [Related]

  • 19. Reduced bone marrow colony growth in hairy-cell leukemia before and after interferon-alpha treatment. Possible inhibitory role of a serological factor.
    Lauria F, Bagnara GP, Guarini A, Catani L, Gaggioli L, Gugliotta L, Raspadori D, Macchi S, Zauli G, Zinzani PL.
    Haematologica; 1988 Jun; 73(3):191-4. PubMed ID: 3139514
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.